account_balance
Investment manager · 13F filer · SEC CIK 1813845
BIOS Capital Management, LP
Reported value$41.7Mas of Jun 30, 2026
Positions6 0 new, 0 sold out
Top 10 weight100%ACTU alone is 37%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
ACTU
Actuate Therapeutics INC
36.9%
IRD
Opus Genetics INC
36.3%
CGTX
Cognition Therapeutics INC
16.6%
RNTX
Rein Therapeutics INC
7.4%Added
LTRN
Lantern Pharma INC
2.5%Trimmed
INAB
0.3%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed